Showing results (11-20 of 100) with videos related to

Sort By:
Pageof 10
BMC Cancer|August 14, 2023
Efficacy and safety of fluzoparib combined with anlotinib in extensive stage small cell lung cancer after first-line platinum-based chemotherapy: a multi-center, single-arm prospective phase II clinical study (STAMP study)Deyu Li, Zhangzhou Huang, Jiangming Zhong, et al.
Journal of Translational Medicine|February 23, 2019
Crizotinib with or without an EGFR-TKI in treating EGFR-mutant NSCLC patients with acquired MET amplification after failure of EGFR-TKI therapy: a multicenter retrospective studyWenxian Wang, Hong Wang, Peihua Lu, et al.
Medicine|November 7, 2019
Bladder cancer survival nomogram: Development and validation of a prediction tool, using the SEER and TCGA databasesYe Zhang, Ying-Kai Hong, Dong-Wu Zhuang, et al.
BMC Cancer|April 2, 2020
In silico analysis of the immune microenvironment in bladder cancerYe Zhang, De-Hua Ou, Dong-Wu Zhuang, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|June 28, 2018
[Efficacy of S-1 in Advanced Non-small Cell Lung Cancer Patients Treated with More Than Two Lines of Chemotherapy]Yi Yin, Biao Wu, Zhangzhou Huang, et al.
Journal of Cellular and Molecular Medicine|January 25, 2018
Co-expression of NF-κB-p65 and phosphorylated NF-κB-p105 is associated with poor prognosis in surgically resectable non-small cell lung cancerGen Lin, Chao Li, Cheng Huang, et al.
Thoracic Cancer|May 9, 2018
Clonally-related primary ALK rearranged adenocarcinoma and associated metastatic lesionsYou-Cai Zhu, Yun-Te Deng, Wen-Xian Wang, et al.
American Journal of Translational Research|May 2, 2020
LncRNA H19/Runx2 axis promotes VSMCs transition via MAPK pathwayFang Liu, Xin-Chun Yang, Mu-Lei Chen, et al.
Zhonghua Jie He He Hu Xi Za Zhi = Zhonghua Jiehe He Huxi Zazhi = Chinese Journal of Tuberculosis and Respiratory Diseases|January 16, 2014
[The efficacy and adverse effects of individualized treatment for elderly patients with epidermal growth factor receptor wild-type non-small cell lung cancer under the guidance of molecular markers]Cheng Huang, Biao Wu, Zhi-yong He, et al.
Thoracic Cancer|March 9, 2018
CEP72-ROS1: A novel ROS1 oncogenic fusion variant in lung adenocarcinoma identified by next-generation sequencingYou-Cai Zhu, Yue-Fen Zhou, Wen-Xian Wang, et al.
Pageof 10